$0.80
+0.00 (+0.06%)
Open$0.81
Previous Close$0.80
Day High$0.85
Day Low$0.79
52W High$46.45
52W Low$0.76
Volume—
Avg Volume58.6K
Market Cap1.62M
P/E Ratio—
EPS$-79.18
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.37M | 777.7K | 707.3K |
| Net Income | -124,210,687 | 128.9K | 94.3K |
| Profit Margin | -489.6% | 16.6% | 13.3% |
| EBITDA | -87,963,509 | 197.3K | 212.4K |
| Free Cash Flow | — | 80.3K | 76.9K |
| Rev Growth | +172.4% | -2.7% | +7.8% |
| Debt/Equity | 0.08 | 0.46 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |